Jaguar Health, Inc.
JAGX
$1.76
-$0.03-1.68%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.81M | 11.55M | 11.69M | 10.48M | 10.19M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.81M | 11.55M | 11.69M | 10.48M | 10.19M |
| Cost of Revenue | 2.14M | 2.04M | 1.96M | 2.09M | 2.06M |
| Gross Profit | 9.67M | 9.51M | 9.73M | 8.40M | 8.13M |
| SG&A Expenses | 26.95M | 25.59M | 24.02M | 22.78M | 22.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 44.66M | 43.59M | 42.52M | 40.34M | 41.57M |
| Operating Income | -32.85M | -32.04M | -30.83M | -29.86M | -31.39M |
| Income Before Tax | -41.41M | -40.48M | -39.25M | -38.33M | -36.21M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -41.41 | -40.48 | -39.25 | -38.33 | -36.21 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 766.00K | 749.00K | 759.00K | 584.00K | 543.00K |
| Net Income | -40.65M | -39.73M | -38.49M | -37.74M | -35.67M |
| EBIT | -32.85M | -32.04M | -30.83M | -29.86M | -31.39M |
| EBITDA | -30.94M | -30.16M | -28.93M | -27.94M | -29.43M |
| EPS Basic | -74.07 | -66.47 | -136.90 | -397.50 | -933.77 |
| Normalized Basic EPS | -44.62 | -41.04 | -91.98 | -246.38 | -745.43 |
| EPS Diluted | -74.07 | -66.47 | -136.90 | -397.50 | -933.77 |
| Normalized Diluted EPS | -44.62 | -41.04 | -91.98 | -246.38 | -745.43 |
| Average Basic Shares Outstanding | 2.49M | 5.05M | 4.53M | 4.09M | 3.73M |
| Average Diluted Shares Outstanding | 2.49M | 5.05M | 4.53M | 4.09M | 3.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |